Your browser doesn't support javascript.
loading
Gastric inhibitory polypeptide immunoneutralization attenuates development of obesity in mice.
Boylan, Michael O; Glazebrook, Patricia A; Tatalovic, Milos; Wolfe, M Michael.
Affiliation
  • Boylan MO; Division of Gastroenterology, MetroHealth Medical Center and Case Western Reserve University, Cleveland, Ohio.
  • Glazebrook PA; Division of Gastroenterology, MetroHealth Medical Center and Case Western Reserve University, Cleveland, Ohio.
  • Tatalovic M; Division of Gastroenterology, MetroHealth Medical Center and Case Western Reserve University, Cleveland, Ohio.
  • Wolfe MM; Division of Gastroenterology, MetroHealth Medical Center and Case Western Reserve University, Cleveland, Ohio michael.wolfe2@case.edu.
Am J Physiol Endocrinol Metab ; 309(12): E1008-18, 2015 Dec 15.
Article in En | MEDLINE | ID: mdl-26487006
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Gastric Inhibitory Polypeptide / Antibodies, Neutralizing / Obesity Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals Language: En Year: 2015 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Gastric Inhibitory Polypeptide / Antibodies, Neutralizing / Obesity Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals Language: En Year: 2015 Type: Article